These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 33206300

  • 21. Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation.
    Pohjantähti-Maaroos H, Hyppölä H, Lekkala M, Sinisalo E, Heikkola A, Hartikainen J.
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):114-120. PubMed ID: 28849946
    [Abstract] [Full Text] [Related]

  • 22. Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.
    Simon A, Niederdoeckl J, Skyllouriotis E, Schuetz N, Herkner H, Weiser C, Laggner AN, Domanovits H, Spiel AO.
    Europace; 2017 Feb 01; 19(2):233-240. PubMed ID: 28175295
    [Abstract] [Full Text] [Related]

  • 23. Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation?
    Conde D.
    Int J Cardiol; 2013 Oct 30; 169(2):95-6. PubMed ID: 24071384
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia-Pacific Region: A Phase 3 Randomized Controlled Trial.
    Beatch GN, Bhirangi K, Juul-Moller S, Rustige J.
    J Cardiovasc Pharmacol; 2017 Feb 30; 69(2):86-92. PubMed ID: 27828791
    [Abstract] [Full Text] [Related]

  • 25. Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.
    Conde D, Costabel JP, Aragon M, Lambardi F, Klein A, Corrales Barbosa A, Trivi M, Giniger A.
    Cardiovasc Ther; 2013 Dec 30; 31(6):377-80. PubMed ID: 23683253
    [Abstract] [Full Text] [Related]

  • 26. Population pharmacokinetic-pharmacodynamic analysis of vernakalant hydrochloride injection (RSD1235) in atrial fibrillation or atrial flutter.
    Mao Z, Wheeler JJ, Townsend R, Gao Y, Kshirsagar S, Keirns JJ.
    J Pharmacokinet Pharmacodyn; 2011 Oct 30; 38(5):541-62. PubMed ID: 21786177
    [Abstract] [Full Text] [Related]

  • 27. Vernakalant. Too dangerous in atrial fibrillation.
    Prescrire Int; 2012 May 30; 21(127):119-22. PubMed ID: 22827000
    [Abstract] [Full Text] [Related]

  • 28. [Vernakalant for the conversion of atrial fibrillation of recent onset].
    Seoane L, Baranchuk A, Conde D.
    Medicina (B Aires); 2015 May 30; 75(4):239-44. PubMed ID: 26339882
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial.
    Camm AJ, Toft E, Torp-Pedersen C, Vijayaraman P, Juul-Moller S, Ip J, Beatch GN, Dickinson G, Wyse DG, Scene 2 Investigators.
    Europace; 2012 Jun 30; 14(6):804-9. PubMed ID: 22291438
    [Abstract] [Full Text] [Related]

  • 30. Vernakalant: A novel agent for the termination of atrial fibrillation.
    Finnin M.
    Am J Health Syst Pharm; 2010 Jul 15; 67(14):1157-64. PubMed ID: 20592320
    [Abstract] [Full Text] [Related]

  • 31. Vernakalant: conversion of atrial fibrillation in patients with ischemic heart disease.
    Torp-Pedersen C, Camm AJ, Butterfield NN, Dickinson G, Beatch GN.
    Int J Cardiol; 2013 Jun 05; 166(1):147-51. PubMed ID: 22108512
    [Abstract] [Full Text] [Related]

  • 32. A new antiarrhythmic drug in the treatment of recent-onset atrial fibrillation: vernakalant.
    Vizzardi E, Salghetti F, Bonadei I, Gelsomino S, Lorusso R, D'Aloia A, Curnis A.
    Cardiovasc Ther; 2013 Oct 05; 31(5):e55-62. PubMed ID: 23398692
    [Abstract] [Full Text] [Related]

  • 33. [Vernakalant in hospital emergency practice: safety and effectiveness].
    Carbajosa Dalmau J, Cosín-Sales J, Pérez-Durá MJ, Noceda J, Urtubia-Palacios A, Hernández-Sori N, Peiró-Gómez A, Jacob J, Llorens P, Ruescas-Gómez L, Martín-Martínez A.
    Emergencias; 2013 Oct 05; 29(6):397-402. PubMed ID: 29188914
    [Abstract] [Full Text] [Related]

  • 34. Implementing vernakalant: a novel approach to cardioversion.
    Hall A.
    Emerg Nurse; 2018 Dec 21; 27(1):14-20. PubMed ID: 30550052
    [Abstract] [Full Text] [Related]

  • 35. Use of intravenous vernakalant for atrial fibrillation conversion in the regular ward under only bedside monitoring.
    Manolis AS, Bethanis S, Metaxa S, Polytarchou K, Sakellaris N, Pyrros I.
    Hellenic J Cardiol; 2019 Dec 21; 60(1):54-56. PubMed ID: 29454598
    [No Abstract] [Full Text] [Related]

  • 36. Vernakalant--a promising therapy for conversion of recent-onset atrial fibrillation.
    Naccarelli GV, Wolbrette DL, Samii S, Banchs JE, Penny-Peterson E, Stevenson R, Gonzalez MD.
    Expert Opin Investig Drugs; 2008 May 21; 17(5):805-10. PubMed ID: 18447605
    [Abstract] [Full Text] [Related]

  • 37. Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation.
    Conde D, Costabel JP, Caro M, Ferro A, Lambardi F, Corrales Barboza A, Lavalle Cobo A, Trivi M.
    Int J Cardiol; 2013 Oct 03; 168(3):2423-5. PubMed ID: 23518212
    [Abstract] [Full Text] [Related]

  • 38. Vernakalant for the conversion of atrial fibrillation: the new kid on the block?
    Conde D, Baranchuk A.
    Ann Noninvasive Electrocardiol; 2014 Jul 03; 19(4):299-302. PubMed ID: 24738652
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors.
    Mao ZL, Wheeler JJ, Clohs L, Beatch GN, Keirns J.
    J Clin Pharmacol; 2009 Jan 03; 49(1):17-29. PubMed ID: 18927241
    [Abstract] [Full Text] [Related]

  • 40. Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion.
    Müssigbrodt A, John S, Kosiuk J, Richter S, Hindricks G, Bollmann A.
    Europace; 2016 Jan 03; 18(1):51-6. PubMed ID: 26056189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.